| Mepha Pharma AG - Clarithromycin-Mepha 250, Granulat zur Herstellung einer Suspension zum Einnehmen | | 57192 | | 02 | | Clarithromycin-Mepha 250 | | Granulat zur Herstellung einer Suspension zum Einnehmen | | J01FA09 | | Clarithromycin | | 11.05.2005 | | |
| | Composition | | clarithromycinum 250 mg, poloxamerum 188, povidonum K 30, hypromellosum, macrogolum 6000, acidi methacrylici et ethylis acrylatis polymerisatum 1:1, triethylis citras, glyceroli monostearas 40-55, polysorbatum 80, silica colloidalis anhydrica, xanthani gummi, aromatica (Fruchtmischung), saccharum 2.4 g, maltodextrinum, E 1450, E 171, E 202, ad granulatum corresp., suspensio reconstituta 5 ml. | | Packungsbestandteile | | Granulat zur Herstellung einer Suspension zum Einnehmen | | | | | Active Agent | Dose |
|---|
| Clarithromycin | 250 mg |
| | BAG: Active Agent | Dose |
|---|
| Clarithromycin | 250 mg |
| | | | Inactive agents | Dose | additional_information |
|---|
| Acidi Methacrylici | | | | Ad Granulatum | | | | Aromatica (Fruchtmischung) | | | | E 1450 | | color. | | E 171 | | color. | | E 202 | | conserv. | | Ethylis Acrylatis Polymerisatum | | | | Glyceroli Monostearas | 40-55 | | | Hypromellosum | | | | Macrogol | 6000 | | | Maltodextrine | | | | Poloxamer | 188 | | | Polysorbatum 80 | | | | Povidonum K | 30 | | | Saccharum | 2.4 g | | | Silica Colloidalis Anhydrica | | | | Triethylis Citras | | | | Xanthani Gummi | | |
| |
| | Package number | Package Size | EFP | CP | Category | SL | Out of trade (MedRef) |
|---|
| 004 | 100 ml | 9.98 | 27.25 | A | SL | No |
|
|
